RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 279 - per page Next page
Order by
Astellas/GlaxoSmithKline's Vesicare has advantages over Pfizer's Detrol LA/Detrusitol XL in reducing episodes of Urge Urinary Incontinence
Superior side-effect profile earns Vesicare gold standard status over sales-leading Detrol LA/Detrusitol XL, according to a new report from Decision Resources More
Robust sales of Integrilin, Reopro and Aggrastat will drive the
Premium priced drug classes account for 70 percent of market sales, More
TRANSDERMAL ANNOUNCES SUCCESSFUL DELIVERY OF DIAZEPAM THROUGH INTACT SKIN
TDS System achieves first-ever transdermal delivery of Diazepam. More
PharmaEssentia announces milestone in development of new third-generation interferon hepatitis B and C drug candidate
Drug development company PharmaEssentia Corp. announced that new PK/PD data on P1101, its third-generation PEG-INF-alpha drug candidate for hepatitis B and C, is particularly long-lasting compared to the two other pegylated drugs on the market. More
Prevalence of Type 2 Diabetes in India is among the highest in the world and growing
Insulins and other expensive agents are out of reach of most Indian patients, according to a report from Decision Resources More
Biosimilar Monoclonal Antibodies in Oncology will approach blockbuster status by 2017
Opportunity for Biosimilars varies significantly by therapeutic area, according to a new report from Decision Resources More
Sales of emerging therapies, most notably Tanezumab and Tapentadol, will nearly double the Chronic Low Back Pain market by 2017
Overall market will increase to US$ 6.9 billion over the next decade, according to a new report from Decision Resources More
PHARMEXX PROMOTE PAVACOL® D (pholcodine sugar free cough medicine)
Sales organisation Pharmexx has been appointed by Alliance Pharmaceuticals to raise the profile of Pavacol D in pharmacy. More
Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors
Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors More
Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor may offer advantages in the treatment of Post-Myocardial Infarction
Considerable opportunity remains for an Antiplatelet therapy that, combined with Aspirin, causes less bleeding than the combination of Plavix/Iscover and Aspirin, according to a new report from Decision Resources More
Displaying 1..10 of 279 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
BPO in EMEA (Databook)
Dec 2006 - 62 pages - $1,295
Trends in wholesaler profitability
Jun 2009 - 23 pages - $1,395
Trends in BPO services (Databook)
Dec 2006 - 29 pages - $1,295
Top 10 Companies in South Africa Manufacturing Industry: IT Spending Predictor 2009
Jun 2009 - 89 pages - $695
BPO in North America (Databook)
Dec 2006 - 23 pages - $1,295
Top 10 Companies in France Telecommunications Industry: IT Spending Predictor 2009
Jun 2009 - 89 pages - $695
Top 10 Companies in Germany Transportation and Logistics Industry: IT Spending Predictor 2009
Jun 2009 - 89 pages - $695
Consumer Logistics Spending in the UK to 2013
May 2010 - 111 pages - $995
Top 10 Companies in Japan Telecommunications Industry: IT Spending Predictor 2009
Jun 2009 - 89 pages - $695
Top 10 Companies in France Energy and Utilities Industry: IT Spending Predictor 2009
Jun 2009 - 89 pages - $695
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us